BR9811365A - Gene de calpaìna capn6, construção de gene, sequência de aminoácidos, processos para identificar inibidores de calpaìna e para preparar a enzima capn6 e suas variantes ou análogos alélicos, e, usos de um inibidor de calpaìna, de uma sequência de aminoácidos e de genes, do mrna anti-sentido e de um gene de calpaìna e suas variantes ou análogos alélicos - Google Patents

Gene de calpaìna capn6, construção de gene, sequência de aminoácidos, processos para identificar inibidores de calpaìna e para preparar a enzima capn6 e suas variantes ou análogos alélicos, e, usos de um inibidor de calpaìna, de uma sequência de aminoácidos e de genes, do mrna anti-sentido e de um gene de calpaìna e suas variantes ou análogos alélicos

Info

Publication number
BR9811365A
BR9811365A BR9811365-8A BR9811365A BR9811365A BR 9811365 A BR9811365 A BR 9811365A BR 9811365 A BR9811365 A BR 9811365A BR 9811365 A BR9811365 A BR 9811365A
Authority
BR
Brazil
Prior art keywords
calpain
gene
capn6
allelic
analogues
Prior art date
Application number
BR9811365-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Thomas Boehm
Neil T Dear
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of BR9811365A publication Critical patent/BR9811365A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96466—Cysteine endopeptidases (3.4.22)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
BR9811365-8A 1997-08-26 1998-08-19 Gene de calpaìna capn6, construção de gene, sequência de aminoácidos, processos para identificar inibidores de calpaìna e para preparar a enzima capn6 e suas variantes ou análogos alélicos, e, usos de um inibidor de calpaìna, de uma sequência de aminoácidos e de genes, do mrna anti-sentido e de um gene de calpaìna e suas variantes ou análogos alélicos BR9811365A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19737105A DE19737105A1 (de) 1997-08-26 1997-08-26 Neue gewebsspezifische Calpaine, ihre Herstellung und Verwendung
PCT/EP1998/005275 WO1999010480A2 (fr) 1997-08-26 1998-08-19 Nouvelles calpaines specifiques au tissu, leur production et leur utilisation

Publications (1)

Publication Number Publication Date
BR9811365A true BR9811365A (pt) 2000-08-22

Family

ID=7840195

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9811365-8A BR9811365A (pt) 1997-08-26 1998-08-19 Gene de calpaìna capn6, construção de gene, sequência de aminoácidos, processos para identificar inibidores de calpaìna e para preparar a enzima capn6 e suas variantes ou análogos alélicos, e, usos de um inibidor de calpaìna, de uma sequência de aminoácidos e de genes, do mrna anti-sentido e de um gene de calpaìna e suas variantes ou análogos alélicos

Country Status (13)

Country Link
EP (1) EP1009811A2 (fr)
JP (1) JP2001513992A (fr)
KR (1) KR20010023282A (fr)
CN (1) CN1277634A (fr)
AU (1) AU9263598A (fr)
BR (1) BR9811365A (fr)
CA (1) CA2301815A1 (fr)
DE (1) DE19737105A1 (fr)
HU (1) HUP0004027A2 (fr)
IL (1) IL134361A0 (fr)
NO (1) NO20000961L (fr)
WO (1) WO1999010480A2 (fr)
ZA (1) ZA987660B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19928021A1 (de) * 1999-06-18 2000-12-21 Basf Ag Neue Calpaine und deren Verwendung
JP2003527091A (ja) * 1999-09-09 2003-09-16 ミレニアム・ファーマシューティカルズ・インコーポレイテッド 新規カルパインプロテアーゼ２６１７６およびその使用
WO2001073073A2 (fr) * 2000-03-28 2001-10-04 Bayer Aktiengesellschaft Regulation d'enzymes apparentees a des proteases neutres humaines
AUPQ656500A0 (en) * 2000-03-28 2000-04-20 Autogen Pty Ltd A method of treatment and agents for same
US20040096869A1 (en) * 2001-04-04 2004-05-20 Daniel Martineau Antisense calpain nucleotides and uses thereof
JP4593404B2 (ja) * 2005-08-29 2010-12-08 シスメックス株式会社 液体試料吸引監視方法及び装置、並びに液体試料分析装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE268816T1 (de) * 1994-07-15 2004-06-15 Cephalon Inc In baculovirus exprimiertes aktives calpain
EP0799892A3 (fr) * 1996-04-05 1998-08-12 Takeda Chemical Industries, Ltd. Calpain, sa préparation et son utilisation

Also Published As

Publication number Publication date
HUP0004027A2 (en) 2001-03-28
IL134361A0 (en) 2001-04-30
NO20000961D0 (no) 2000-02-25
WO1999010480A2 (fr) 1999-03-04
CN1277634A (zh) 2000-12-20
NO20000961L (no) 2000-04-14
CA2301815A1 (fr) 1999-03-04
EP1009811A2 (fr) 2000-06-21
KR20010023282A (ko) 2001-03-26
WO1999010480A3 (fr) 1999-05-27
ZA987660B (en) 2000-02-25
DE19737105A1 (de) 1999-03-04
AU9263598A (en) 1999-03-16
JP2001513992A (ja) 2001-09-11

Similar Documents

Publication Publication Date Title
IL128079A0 (en) Thiol sulfone metalloprotease inhibitors
DE69133602D1 (de) Pflanzliche Thioesterasen
DE69637307D1 (de) Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer
ATE218336T1 (de) Verwendung von 3-benzoylphenylessigsäuren, deren estern oder amiden zur behandlung von glc1a glaukom
WO1995034538A3 (fr) Purification de proteases serines, et leurs inhibiteurs synthetiques
PT94016A (pt) Processo para a producao de inibidores de proteinases
ATE103632T1 (de) Enzymatische waschmittelzusammensetzung und verfahren zum stabilisieren der enzyme.
BR9712111A (pt) Detergentes líquidos contendo enzima proteolítica e inibidores da protease.
ATE259640T1 (de) Verwendung von matrix-metalloproteinase inhibitoren zur förderung der wundheilung
DE69018113D1 (de) Hemmer der Proteasen von Retroviren.
PT975761E (pt) Interferao beta humano recombinante com solubilidade melhorada
MX20503A (es) Quimopapaina y procedimiento para purificarla
ATE108205T1 (de) Rekombinantverfahren zur herstellung von serinproteaseinhibitoren, sowie dns-sequenzen dazu.
BR9811365A (pt) Gene de calpaìna capn6, construção de gene, sequência de aminoácidos, processos para identificar inibidores de calpaìna e para preparar a enzima capn6 e suas variantes ou análogos alélicos, e, usos de um inibidor de calpaìna, de uma sequência de aminoácidos e de genes, do mrna anti-sentido e de um gene de calpaìna e suas variantes ou análogos alélicos
BR9815469A (pt) Inibidores de protease
Stawowy et al. Proprotein convertases regulate insulin-like growth factor 1-induced membrane-type 1 matrix metalloproteinase in VSMCs via endoproteolytic activation of the insulin-like growth factor-1 receptor
WO2000034511A3 (fr) ANALYSE SELECTIVE DE Aβ-PEPTIDE
DE69432795D1 (de) Porphyromonas gingivalis arginin-spezifische proteinase kodierende sequenzen
BR9713849A (pt) Gene de calpaìna ncl-3, construção de gene, sequência de aminoácidos, processos para identificar inibidores de calpaìna e para preparar a enzina ncl3, e usos de um inibidor de calpaìna, da calpaìna ncl-3, de uma sequência de genes, do mrna anti-sentido e de um gene de calpaìna.
PT996709E (pt) Inibidores de enzimas celuloliticas, xilanoliticas e betaglucanoliticas
BR9711540A (pt) Inibidores de protease proteìnico estabilizados e variantes dos mesmos
Hammani et al. Cloning and sequencing of a cDNA encoding mouse stromelysin 1
ATE364700T1 (de) Bestandteil von bromelain
DE59410423D1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
BR0314120A (pt) Processo para a diminuição dos nìveis de agregado de proteìna peguilada

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A, 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007.